Latest Insider Transactions at Aytu Biopharma, Inc (AYTU)
This section provides a real-time view of insider transactions for Aytu Biopharma, Inc (AYTU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AYTU BIOPHARMA, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AYTU BIOPHARMA, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.89%
|
-
|
|
Jun 30
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.9%
|
-
|
|
Mar 31
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.91%
|
-
|
|
Dec 31
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.92%
|
-
|
|
Sep 30
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.92%
|
-
|
|
Aug 16
2023
|
Abhinav Jain |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+44.83%
|
-
|
|
Aug 11
2023
|
Vivian H Liu |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+44.9%
|
-
|
|
Aug 11
2023
|
Abhinav Jain |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+50.0%
|
-
|
|
Aug 11
2023
|
John Donofrio Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+39.87%
|
-
|
|
Aug 11
2023
|
Carl Dockery |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+14.37%
|
-
|
|
Jun 30
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.93%
|
-
|
|
Jun 16
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+35.36%
|
$12,000
$1.87 P/Share
|
|
Jun 14
2023
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
14,000
+16.36%
|
$14,000
$1.86 P/Share
|
|
Apr 25
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+7.74%
|
-
|
|
Feb 08
2023
|
Vivian H Liu |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+48.78%
|
-
|
|
Dec 21
2022
|
Gary Cantrell Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-19.6%
|
-
|
|
Dec 21
2022
|
John Donofrio Jr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
187,804
-92.48%
|
-
|
|
Dec 21
2022
|
Carl Dockery |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-21.19%
|
-
|
|
Dec 20
2022
|
Joshua R. Disbrow Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
80,000
-6.49%
|
-
|
|
Dec 19
2022
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+35.45%
|
$0
$0.24 P/Share
|
|
Dec 19
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
112,371
+8.36%
|
$0
$0.22 P/Share
|
|
Nov 18
2022
|
Mark K Oki Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+32.14%
|
$0
$0.23 P/Share
|
|
Nov 18
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
222,000
+16.55%
|
$0
$0.24 P/Share
|
|
Jul 01
2022
|
Vivian H Liu |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jan 17
2022
|
Mark K Oki Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 16
2021
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+47.13%
|
-
|
|
Apr 16
2021
|
Gary Cantrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+47.92%
|
-
|
|
Apr 16
2021
|
John Donofrio Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+48.05%
|
-
|
|
Apr 16
2021
|
Michael Macaluso Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+47.44%
|
-
|
|
Apr 16
2021
|
Carl Dockery |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+49.87%
|
-
|
|
Apr 08
2021
|
Beth Hecht Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+41.8%
|
-
|
|
Apr 08
2021
|
Gerald W. Mc Laughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.15%
|
-
|
|
Mar 31
2021
|
Richard I Eisenstadt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,000
+44.45%
|
-
|
|
Mar 29
2021
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Mar 29
2021
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Direct |
2,085
+0.16%
|
-
|
|
Mar 20
2021
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Mar 20
2021
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Direct |
6,959
+0.52%
|
-
|
|
Dec 11
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 11
2020
|
Armistice Capital, LLC Director |
BUY
Open market or private purchase
|
Direct |
1,333,334
+50.0%
|
$8,000,004
$6.0 P/Share
|
|
Apr 27
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Apr 27
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
5,108,921
-100.0%
|
$5,108,921
$1.82 P/Share
|
|
Apr 27
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
0
|
-
|
|
Apr 27
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000,000
+49.46%
|
$5,000,000
$1.25 P/Share
|
|
Apr 06
2020
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Apr 06
2020
|
Armistice Capital, LLC Director |
BUY
Other acquisition or disposition
|
Direct |
108,920
+50.0%
|
-
|
|
Mar 10
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Mar 10
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
22,026,801
-94.42%
|
$22,026,801
$1.23 P/Share
|
|
Mar 10
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
0
|
-
|
|
Mar 10
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,229,161
+18.49%
|
$15,229,161
$1.17 P/Share
|
|
Mar 10
2020
|
Armistice Capital, LLC Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
0
|
-
|